首页> 美国卫生研究院文献>The Canadian Journal of Cardiology >Lithium-induced sinus node disease at therapeutic concentrations: Linking lithium-induced blockade of sodium channels to impaired pacemaker activity
【2h】

Lithium-induced sinus node disease at therapeutic concentrations: Linking lithium-induced blockade of sodium channels to impaired pacemaker activity

机译:在治疗浓度下锂诱导的窦房结疾病:将锂诱导的钠通道阻滞与起搏器活动受损联系起来

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present report describes a case of sinus node arrest in a manic-depressive patient being treated with lithium carbonate with a therapeutic serum level of lithium. A permanent rate-modulated ventricular pacemaker was inserted and lithium therapy was continued. A review of literature revealed several other similar case reports in which both therapeutic and toxic levels of serum lithium levels were associated with sinus node dysfunction and bradyarrhythmias. Because lithium is a potent blocker of cardiac sodium channels, and given the critical importance of sodium channels in pacemaker activity, lithium-induced sodium channel blockade is likely an important mechanism in sinus node dysfunction.
机译:本报告描述了在躁狂抑郁症患者中,用治疗性血清锂水平的碳酸锂治疗的窦房结阻滞一例。插入永久性心率调节型心室起搏器,并继续进行锂治疗。文献综述显示了其他一些类似的病例报告,其中血清锂水平的治疗和毒性水平均与窦房结功能障碍和心律失常有关。由于锂是心脏钠通道的有效阻滞剂,并且考虑到钠通道在起搏器活动中至关重要,因此锂诱导的钠通道阻滞可能是窦房结功能障碍的重要机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号